Actualités Pharmadrug Inc - BUZZ | Actions Canadian Securities Exchange

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS...

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT...

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY Toronto...

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - PharmaDrug Inc. (CSE:...

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD FOR PSYCHEDELIC...

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND Provides update on german operations and balance sheet improvements...

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC. Toronto, Ontario -- February 2, 2021 -- InvestorsHub...

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC. WHO RECENTLY RECEIVED ORPHAN DRUG DESIGNATION FROM FDA FOR...

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC. Toronto, Ontario -- January 12, 2021 -- InvestorsHub...

Aura Announces Pharmadrug Operational & Investor Relations Update

TORONTO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ, OTCQB:LMLLF...

Aura Signs Master Grower for Israel

TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased...

Aura Provides Clarification on Pharmadrug’s Supply Agreements and Relationship With Bedrocan

TORONTO, June 07, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) wishes to...

Aura Provides Update on Pharmadrug and Its European Strategy

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR...

Aura Signs Definitive Agreement Disposing of U.S. Cannabis Certification Clinics

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR...

Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Tra...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmadrug Inc (BUZZ)

Outils de qualité professionnelle, pour des investisseurs individuels.

BUZZ Actualités

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC

Aura Announces Pharmadrug Operational & Investor Relations Update

Aura Signs Master Grower for Israel

Aura Provides Clarification on Pharmadrug’s Supply Agreements and Relationship With Bedrocan

Aura Provides Update on Pharmadrug and Its European Strategy

Aura Signs Definitive Agreement Disposing of U.S. Cannabis Certification Clinics

Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Tra...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmadrug Inc (BUZZ) Actualités

Pharmadrug Inc (BUZZ)

Outils de qualité professionnelle, pour des investisseurs individuels.

BUZZ Actualités

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC

Aura Announces Pharmadrug Operational & Investor Relations Update

Aura Signs Master Grower for Israel

Aura Provides Clarification on Pharmadrug’s Supply Agreements and Relationship With Bedrocan

Aura Provides Update on Pharmadrug and Its European Strategy

Aura Signs Definitive Agreement Disposing of U.S. Cannabis Certification Clinics

Aura Health Announces $5.82 Million Closing of the Second Tranche of Its Subscription Receipt Offering and Share Exchange Tra...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application